Immunosuppressant-associated eruptions in pediatric inflammatory bowel disease: A case-control study.

Pollard, Bruin; Utterson, Elizabeth C; Samson, Charles M; Coughlin, Carrie C

Pollard, Bruin; Utterson, Elizabeth C; Samson, Charles M; Coughlin, Carrie C.

Afiliación

Pollard B; Medical Education Program, Washington University School of Medicine, St. Louis, Missouri, USA.
Utterson EC; Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
Samson CM; Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
Coughlin CC; Division of Dermatology, Departments of Medicine and Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.

Pediatr Dermatol ; 39(4): 563-566, 2022 Jul.

Article en En | MEDLINE | ID: mdl-35342990

Asunto(s)

Exantema; Enfermedades Inflamatorias del Intestino; Adalimumab/efectos adversos; Estudios de Casos y Controles; Niño; Exantema/inducido químicamente; Humanos; Inmunosupresores/efectos adversos; Enfermedades Inflamatorias del Intestino/tratamiento farmacológico; Infliximab/efectos adversos; Factor de Necrosis Tumoral alfa

Palabras clave

Crohn's disease; adalimumab; eczema; immunosuppression; inflammatory bowel disease; infliximab; psoriasis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Exantema Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Pediatr Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google